Top 9 Biotech Startups from Disrupt Startup Battlefield

Every year, TechCrunch’s Startup Battlefield competition attracts thousands of applicants. We narrow these entries down to the top 200 contenders, and among them, the top 20 compete on the big stage to become the winners, taking home the Startup Battlefield Cup and a $100,000 cash prize. But the remaining 180 startups all also impressed us in their own categories and competed in their own competition.

Here’s the full list of those selected for the Startup Battlefield 200 biotech and pharma competition, along with a note on why they made it into the competition.

CasNx

What does: CasNx has invented a new type of antiviral therapy for organs from organ donors.

Why it’s noteworthy: The startup has invented a CRISPR gene-editing kit that eliminates viruses and locks in “universal donor” markers while preserving the organ outside the body.

Chibiron

What does: Chipiron is building a lightweight, inexpensive, open, whole-body MRI that aims to make MRI cancer diagnosis more widely available.

Why it’s noteworthy: The medical MRI machine is built using a superconducting quantum interference device (SQUID), a highly sensitive magnetometer that can measure extremely weak magnetic fields, and is most commonly used in array antennas.

Accuracy

What does he do?: Exactics is building a platform that creates rapid diagnostic tests.

Why it’s noteworthy: Exactics is trying to make consumer diagnostic kits more widely available, starting with home testing for Lyme disease, with kits for other diseases on the road map.

Lumos Strategies OÜ

What does he do?: Lumos has created a consumer high-frequency electromagnetic device called Avara, which targets red blood cells.

Why it’s noteworthy: Avara is designed to provide gentle, non-contact “inductive therapy” to improve sleep, relaxation and exercise.

Miracles

What does: Miraculis developed nanotechnology in powder form that mimics blood clotting proteins.

Why it’s noteworthy: This technology provides immediate blood clotting and is a unique, potentially life-saving alternative to traditional wound treatments, especially when treating patients at the site of an injury.

Nephrogen

What does he do?: Nephrogen creates gene therapy solutions for kidney disease.

Why it’s noteworthy: Nephrogen solves the hardest part of the problem when it comes to gene editing drugs. Its technology uses artificial intelligence to precisely target gene editing to the specific cells in the kidney that are causing the disease.

PraxisPro

What does: PraxisPro is an AI-powered training system for sales and marketing roles in life sciences industries.

Why it’s noteworthy: The system provides certified compliance content, complete with real-time simulations and analysis to ensure those representing life sciences companies are properly prepared to do so.

Remy D

What does: Reme-D develops reliable and affordable diagnostic tests specifically targeted to underserved communities.

Why it’s noteworthy: Reme-D is developing rapid diagnostic tests that are not only affordable but also stable in hot and humid climates.

Surgical techniques

What does: Surgicure has created a patented solution that secures endotracheal (ET) tubes more safely and reliably.

Why it’s noteworthy: This device makes ET tubes, which are flexible tubes that are inserted through the mouth or nose during surgeries or other treatments, safer and more comfortable for patients.